Study: ED-ICU Collaboration Reduced Sepsis Mortality, Costs
"Although ICU level of care is costly, earlier inclusion of borderline patients may improve mortality," says lead researcher Joseph Carrington, MD, Northwest Hospital and Lifebridge Critical Care in Randallstown, Maryland. "It may also significantly decrease resource utilisation, as our study found."
For this study, Dr. Carrington and his colleague, Jaime Barnes, DO, also of Northwest Hospital, reviewed 886 medical records from patients with sepsis admitted to the ICU of a community hospital. There was collaboration between the ED and ICU in admitting traditionally “borderline” patients to the ICU, as well as utilising standardised ICU admission criteria for septic patients.
The researchers compared mortality and length of stay before and after making ICU admission criteria less stringent for patients with sepsis. They found that upon easing of ICU admission criteria, overall mortality decreased by 45.4 percent (from 14.38 percent to 7.85 percent). Although the severity of the illness did not change, ICU length of stay was 25.9 percent lower in the post-implementation cohort (3.97 days vs. 2.94 days). In addition, the number of intermediate care unit patients who were transferred to the ICU also decreased by 67.1 percent (from 3.89 percent to 1.28 percent).
"In addition to improved outcomes, annualised cost savings in our new model were $2,286,600 (based on average cost of $2,500/ICU-day)," the authors write.
The results show that developing a collaborative culture between the ED and ICU and lowering ICU admission thresholds not only provide smarter use of ICUs but may also help improve annual cost savings in hospitals, according to the authors.
Further results will be shared during CHEST Annual Meeting 2015, held in Montréal, Canada on 24-28 October.
Source: American College of Chest Physicians
Image credit: Flickr.com
Published on : Fri, 23 Oct 2015
Print as PDF
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
The iLA Membrane Ventilator is an extrapulmonary ventilation system which is used primarily to remove carbon dioxide. The heart pumps blood through it as it does through a natural organ. The gas exchange takes place via a plasma-tight, heparin-coated...
NovaPort cannulas are designed specially to meet the needs of extracorporeal lung and heart support circuits and perioperative perfusion in minimally invasive heart surgery.All blood-contact surfaces of the NovaPort cannulas are coated with the bio- and...
17 critical parameters from a blood sample as small as 45 µL Not available in the US When the sample is small but your diagnostic needs are big, the ABL90 FLEX PLUS blood gas analyzer provides critical insights with a turnaround time of less than...
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....